Full length membrane proteins are often unstable and rapidly lose activity after solubilization in buffer. DIMA Biotech has pooled expertise in the cutting-edge technologies of membrane proteins and developed several development platforms for different proteins. Unlike other full length transmembrane proteins, DIMA’s proteins have shown high activities and great stabilities even after lyophilization and in the accelerated testing.

Human CLDN18.2 full length protein-VLP (Cat#: FLP100006)

High Activity

High Stability

ELISA

Immobilized human CLDN18.2-VLP protein at 0.5μg/per well binds to Anti-CLDN18.2 monoclonal antibody.

Lyophilization test

Accelerated Test (Lyophilized Powder)

Human CD63 full length protein-synthetic nanodisc (Cat#: FLP100030)

High Activity

High Stability

ELISA

Immobilized human CD63-synthetic nanodisc protein at 0.2μg/per well binds to Anti-CD63 monoclonal antibody (DMC100425).

Lyophilization test

Accelerated Test (Lyophilized Powder)

Human CD63 full length protein-MNP (Cat#:FLP100034)

High Activity

High Stability

ELISA

Immobilized human CD63-MNP protein at 0.5μg/per well binds to  Anti-CD63 monoclonal antibody (DMC100425).

Lyophilization test

Accelerated Test (Lyophilized Powder)